Status:
COMPLETED
COVID-19: Herd Immunity Study in the Czech Republic
Lead Sponsor:
Institute of Health Information and Statistics of the Czech Republic
Collaborating Sponsors:
Ministry of Health, Czech Republic
Palacky University
Conditions:
COVID
SARS-CoV 2
Eligibility:
All Genders
8-89 years
Brief Summary
The aim of the SARS-CoV-2-CZ-Preval study is to quantify the prevalence of individuals with a history of SARS-CoV-2 coronavirus infection in the Czech population, except for those diagnosed with COVID...
Detailed Description
COVID-19 is caused by a new type of coronavirus called SARS-CoV-2. It is a highly infectious disease, manifested mainly by fever, respiratory problems, muscle pain, and fatigue. However, despite the p...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- signed Informed Consent
- residing in The Czech Republic
- demographic criteria: (i) persons aged 8-17 (specific children's cohort), (ii) persons aged 18-89
- clinical criteria: (i) without acute health problems (ii) without a confirmed diagnosis of COVID-19
- geographic criteria: according to a particular cohort definition
Exclusion
Key Trial Info
Start Date :
April 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
27000 Patients enrolled
Trial Details
Trial ID
NCT04401085
Start Date
April 23 2020
End Date
May 1 2020
Last Update
June 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Health Information and Statistics of the Czech Republic
Prague, Czechia, 128 01